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2672over-ambitious amateur runners, rather than elite
runners, are placed at the rising slope of the U-sha-
ped relationship between jogging dose and all-cause
mortality. Therefore, novice and amateur runners
could not only optimize their running training and
performance but also their cardiovascular health by
following modern training methods used by elite
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276–91.Sex, Jogging,
and Mortality
The Copenhagen City Heart StudyWe read with great interest both the paper by
Schnohr et al. (1) on the dose of jogging and mor-
tality in the CCHS (Copenhagen City Heart Study)
cohort and the editorial comment by Lee et al. (2).
There is one major confounder in the original paper
we would like to emphasize: sedentary nonjoggers
were more often women (57%) and strenuous joggers
were mostly men (80%). This unbalance is of utter-
most importance for mortality studies because the
men–women life expectancy difference at 44 years
(mean baseline age in the CCHS) was –3.9 years in
Denmark in 2001 (Eurostat). In a previous paper, the
same Danish team reported that jogging could in-
crease survival by 6.2 years in men and 5.6 years in
women (3). Therefore, the effect of sex on the
outcome (mortality) is of the same order of magni-
tude as the effect of the variable of interest(jogging). The only reasonable approach in that case
is to analyze men and women in 2 separate studies.
There is no need to use statistics to test the hy-
pothesis of an effect of sex on mortality, because
this effect is not a hypothesis but a fact. Pooling men
and women together and adjusting by sex can only
decrease the power of the analyses and fails to show
a potential difference between sedentary nonjoggers
and strenuous joggers. A simple rule of thumb
calculation with the previously described estimates
of both sex and jogging effects shows that, compared
with a putative all-men sedentary nonjogger group
of the same age, the sedentary nonjogger and
strenuous jogger groups of the CCHS would have an
increased life expectancy of 4.2 and 3 years,
respectively, which could mistakenly be interpreted
as an increased risk for the strenuous joggers.
Therefore, we strongly recommend men and women
being considered separately when conducting mor-
tality studies.*Olivier Luc Charansonney, MD, MSc
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Mortality Versus LongevityWe read, with great interest, the paper by Schnohr
et al. (1), who investigated the association between
jogging and long-term all-cause mortality. The in-
vestigators reported that light and moderate joggers
had lower mortality rates (hazard ratio [HR]: 0.22;
95% conﬁdence intervals [CI]: 0.10 to 0.47 and HR:
0.66; 95% CI: 0.32 to 1.38, respectively) compared
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2673with sedentary nonjoggers, whereas these health
beneﬁts were absent in strenuous joggers (HR: 1.97;
CI: 0.48 to 8.14). Hence, the investigators concluded
that a U-shaped association between exercise dose
and all-cause mortality was present, which sug-
gested an upper limit of the health beneﬁts of
exercise.
Interestingly, strenuous exercise was established
as >4 h of jogging per week at a fast pace. Although
this amount of physical activity clearly exceeded
the current exercise recommendations, these doses
were typically observed in amateur and professional
athletes. Other studies investigated the life expec-
tancy of athletic populations. Finnish skiers (2) and
world-class endurance athletes (3) demonstrated an
increased life expectancy of 2.8 to 6 years compared
with reference cohorts. A study that included
15,174 Olympic medallists conﬁrmed these ﬁndings,
and found 2.8 years of increased life expectancy
compared with matched cohorts from the general
population (4). Furthermore, a large Swedish study
reported a 52% reduction of all-cause mortality
among participants of the Vasaloppet cross-country
ski-race, with the highest life expectancy found in
older participants and athletes who participated in
multiple races (5).
These ﬁndings suggest that high volumes of
exercise training improve longevity and are in
contradiction to the U-shaped association between
exercise dose and all-cause mortality as suggested by
Schnohr et al (1). The small sample size of the stren-
uous jogger group (n ¼ 40), with only 2 deaths during
the 12 years of follow-up, may contribute to these
conﬂicting ﬁndings. In addition, the lack of insight
into the cause of death may confound the results; if
only 1 of the 2 death cases was caused by a non-
natural death (e.g., accidents, suicide), the study
outcomes would be completely different. Finally, the
arbitrarily chosen cutpoints for classiﬁcation of the
light, moderate, and strenuous jogger groups may not
appropriately reﬂect the spectrum of light to extreme
doses of exercise training.
Therefore, we believe, that the evidence for an
upper limit (>4 h/week) of exercise health bene-
ﬁts and associated all-cause mortality is premature.
With physical inactivity as 1 of the most inﬂuential
risk factors for worldwide morbidity and mortality,
we would recommend to keep on running.Martijn F.H. Maessen, MSc
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Worse Than Sedentarism?Schnohr et al. (1) reported a U-shaped association
between all-cause mortality and exercise dose in a
Danish cohort. Jogging 1 to 2.4 h/week was associated
with the lowest mortality, whereas jogging >3 times/
week was no better than being inactive and was worse
than light jogging (adjusted hazard ratio [HR]: 9.08;
95% conﬁdence interval [CI]: 1.87 to 44.01). Further-
more, older (61.3  16.2 years) sedentary nonjoggers
with cardiovascular disease (CVD) risk factors (high
body mass index, high blood pressure, smoking,
and diabetes) had even lower mortality rates than
younger (37  13.9 years) intense joggers without
these risk factors (adjusted HR: 1.97; 95% CI: 0.48 to
8.14) (1). Besides challenging well-established medi-
cal knowledge (i.e., that physical inactivity is a risk
factor for CVD), the notion that high exercise doses
might be worse than sedentarism for health in a
speciﬁc cohort could lead to misinterpretations and
erroneous generalizations. For example, the press in
Spain recently also suggested a “killing” effect of “too
much exercise.” However, among 10.9 million U.S.
individuals who ran in marathons from 2000 to 2010,
only 59 experienced cardiac arrest/sudden death,
